Insights Center

Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.

Featured

Mintz Direct

On our new Mintz Direct page, Mintz thought leaders across industries and practice areas offer timely insights on developments that impact our clients and communities. Visit the Mintz Direct page to hear what our experienced attorneys and professionals are saying about what’s happening now.

Mintz Viewpoints

Use quotation marks to search for an exact phrase (e.g. “class action”)

Published

Showing 11385 - 11392 of 11616 results

Mintz Achieves Victory for Vertex in First Circuit

Case Study

Pet Food Manufacturer Obtains Settlement in Slack Fill Cases

Case Study

Manufacturer Obtains Reversal of CPSC Enforcement Action

Case Study

Defeated Multiple Appeals of Comprehensive Permit for 150-Unit Housing Development

Case Study

Energy XXI Bankruptcy Holders Receive Cash Payout

Case Study

Advising Trustees and Creditors in LA and TX Bankruptcies

Case Study

Telecom Company in Complex Indemnity Dispute

Case Study

Kansas Bankruptcy Auction Pays Off for Synata Bio

Case Study

News & Press Releases

Mintz Announces New Members

December 20, 2024

Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.

Mintz Advises US Department of Energy LPO on $1.45B Loan Guarantee to Qcells

December 20, 2024

Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.

Dealmaking Dormant No More

December 17, 2024

International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.

View all News and Press Releases